Related Experiment Videos
[B-cell anomalies in systemic lupus erythematosus]
François Tron1, Serge Jacquot, Danièle Gilbert
1Unité INSERM U519, Institut Fédératif de Recherches Multidisciplinaires sur les Peptides (IFR23), Faculté Mixte de Médecine et Pharmacie, CHU Charles-Nicolle, 22, boulevard Gambetta, 76183 Rouen Cedex 1. francois.tron@chu-rouen.fr
Annales De Medecine Interne
|March 1, 2003
Summary
Systemic lupus erythematosus (SLE) involves overactive B cells producing autoantibodies. Genetic factors and B cell receptor signaling defects contribute to inherited lupus susceptibility in mice and humans.
Area of Science:
- Immunology
- Autoimmunity
- Genetics
Context:
- Systemic lupus erythematosus (SLE) is a complex autoimmune disease.
- B lymphocyte hyperactivity and autoantibody production are key features of SLE.
- Murine models offer insights into human SLE pathogenesis.
Purpose:
- To explore the role of B cells in SLE.
- To investigate the genetic basis of B cell hyperactivity in lupus.
- To understand the contribution of B cell receptor signaling defects.
Summary:
- SLE is characterized by B cell hyperactivity and autoantibody production against nuclear antigens.
- Both environmental and genetic factors contribute to B cell hyperactivity in SLE.
- Intrinsic B cell defects, potentially inherited, are implicated in lupus pathogenesis, as seen in murine models with B cell receptor signaling pathway deficiencies.
Impact:
- Understanding B cell hyperactivity and genetic predispositions is crucial for developing targeted SLE therapies.
- Identifying genetic loci associated with B cell hyperactivity can elucidate disease mechanisms.
- Research on murine models advances the comprehension of human autoimmune diseases like SLE.